Clinical Trials in Michigan

Showing 15361-15380 of 16,154 trials

SmartRisk Stroke Prediction by MRI of Carotid Disease

NCT00860184

Atherosclerotic plaque at the carotid artery bifurcation is a major source of stroke. The purpose of this investigation is to determine the ability of the SmartRisk software module to predict stroke or stroke-related events due to carotid plaque within a high-risk population. The SmartRisk software module operates on magnetic resonance images (MRI) of the carotid artery wall.

Atherosclerotic Disease, Carotid

VPDiagnostics300 participantsStarted Nov 2009

Phoenix, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +12 more locations

COMPLETED41 miles

A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen

NCT00135447

The purpose of this study is to find out the frequency of the I50L substitution among patients experiencing treatment failure on an atazanavir-containing regimen.

HIV Infections

Bristol-Myers Squibb5,000 participantsStarted Sep 2004

Phoenix, Arizona, United States • Beverly Hills, California, United States • Beverly Hills, California, United States +81 more locations

SmartRisk Stroke Prediction by MRI of Carotid Disease

A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen

Find Trials by Condition in Michigan

Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen

A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail

A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis

Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

Remission in Subjects With Crohn's Disease, Open Label Extension

Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder

CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI

Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects

ATV/Ritonavir Nevirapine Interaction (USPAC)